Clinical trialNCT07332455RecruitingPhase 1/PHASE2Interventional

First-Time-in-Human Study of GSK5471713 in Adults With mCRPC

SponsorGlaxoSmithKlineEnrollment54Neoplasms, Prostate

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This first-time-in-human study will evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, preliminary clinical activity, and establish the benefit/risk of GSK5471713 given as a monotherapy in mCRPC.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

GSK Clinical Trials
GlaxoSmithKline
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia

Gsk Investigational Site
Melbourne, Victoria, Australia
Arun Azad
Recruiting

Canada

Gsk Investigational Site
Toronto, Ontario, Canada
Srikala Sridhar
Recruiting
Gsk Investigational Site
Montreal, Quebec, Canada
Ramy Saleh
Recruiting

Japan

Gsk Investigational Site
Tokyo, Japan
Yuji Miura
Recruiting
Gsk Investigational Site
Tokyo, Japan
Kazuki Sudo
Recruiting

South Korea

Gsk Investigational Site
Seoul, Seoul Teugbyeolsi, South Korea
Se Hoon Park
Recruiting
Gsk Investigational Site
Seoul, South Korea
Sang Joon Shin
Recruiting

United States

Gsk Investigational Site
La Jolla, California, United States
Rana McKay
Recruiting
Gsk Investigational Site
Grand Rapids, Michigan, United States
Emerson Lim
Recruiting
Gsk Investigational Site
Philadelphia, Pennsylvania, United States
Kevin Zarrabi
Recruiting
Gsk Investigational Site
West Valley City, Utah, United States
Jose Pacheco
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

GSK5471713

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 10 Feb 2026
Primary completion: 24 Mar 2028
Completion: 26 Mar 2030
Last update posted: 24 Jul 2026
Registered enrollment: 54
Registry id: NCT07332455

Cross-registrations

EU-CTR / CTIS (EudraCT)2025-523874-17

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.